[AKEI NEWSLETTER 16호]Pharmaceutical and bio trends "CphI Korea/Hi Korea" a…
Page Info
내용
Pharmaceutical and bio trends "CphI Korea/Hi Korea" at a glance.
An exhibition was held to check trends in the global pharmaceutical and bio industries and health industries. There were 81 participating countries from 10 countries, 63 domestic companies participated, and 18 overseas companies participated.
Various free conferences were also prepared. A total of 21 presentations were prepared through five sessions during the three days of the exhibition. Anyone can apply through the Internet and it was conducted offline and online at the same time.
On the afternoon of the first day, CAIQTEST Korea General Manager Joo-yeon Kim attended the 'Strategies for Response to the 2022 Health Food and Food-Related Import Permit System in China' and the 'Korea-China FTA Preparation Process for Health Food and Food Industry and Issuance of Certificate of Origin' by Yoo Dae-hyeok, a customs company in Seoul. Information sharing continued.
On the second day, under the theme of 'KDRA Innovation Policy Research Center (InnoPol), the first biohealth policy forum in 2021/plan to support the next government's development of the biohealth industry to strengthen the global competitiveness of the biohealth industry,' 'Trends and development tasks of the biohealth industry SK Biopharmaceuticals Vice President Shin Hae-in's 'Measures to support the global expansion of the domestic biohealth industry' Cure Therapeutics CEO Kim Tae-ho's 'Advanced biopharmaceutical technology strategy: First or Best Penguin?' Paminogen CEO Kim Young-hoon's 'A plan to improve productivity of new drug development using AI/big data' Professor Kwon Kyung-hee of Dongguk University's College of Pharmacy presented 'A strategy for advancing licensing regulations'.